Concord Drugs Ltd

AI
Concord Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Concord Drugs Ltd

₹ 77.0 -2.88%
17 Sep - close price
concorddrugs.in BSE: 538965
About

Incorporated in 1995, Concord Drugs Ltd manufactures licensed drugs based on
approved formulations

Key Points

Business Overview:[1]
CDL is a Telangana based company which is in the business of manufacturing licensed bulk drugs and active pharmaceutical intermediates on the approved formulations. Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

Website BSE
  • Market Cap ₹ 101 Cr.
  • Current Price ₹ 77.0
  • High / Low ₹ 92.5 / 61.0
  • Stock P/E 49.5
  • Book Value ₹ 36.8
  • Dividend Yield 0.00 %
  • ROCE 5.46 %
  • ROE 2.57 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -9.31%
  • Company has a low return on equity of 1.73% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
8.98 7.53 12.78 15.64 11.69 12.37 10.80 10.39 13.61 10.28 16.99 37.90 20.95
7.52 5.91 12.15 15.29 10.86 11.49 9.40 9.34 12.59 9.18 16.05 36.40 18.66
Operating Profit 1.46 1.62 0.63 0.35 0.83 0.88 1.40 1.05 1.02 1.10 0.94 1.50 2.29
OPM % 16.26% 21.51% 4.93% 2.24% 7.10% 7.11% 12.96% 10.11% 7.49% 10.70% 5.53% 3.96% 10.93%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.44 0.43 0.50 0.50 0.45 0.47 0.50 0.61 0.49 0.49 0.34 0.40 0.40
Depreciation 0.38 0.39 0.39 0.39 0.34 0.34 0.37 0.38 0.37 0.34 0.31 0.35 0.35
Profit before tax 0.64 0.80 -0.26 -0.54 0.04 0.07 0.53 0.06 0.16 0.27 0.29 0.75 1.54
Tax % 23.44% 30.00% -3.85% -38.89% 50.00% 42.86% 58.49% 33.33% 25.00% 29.63% 27.59% 29.33% 27.92%
0.49 0.56 -0.24 -0.34 0.03 0.04 0.23 0.04 0.12 0.19 0.22 0.53 1.11
EPS in Rs 0.53 0.60 -0.24 -0.34 0.03 0.04 0.23 0.04 0.12 0.19 0.17 0.40 0.84
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
58.96 52.08 44.92 45.24 78.74 86.12
53.37 47.51 40.88 41.10 74.22 80.29
Operating Profit 5.59 4.57 4.04 4.14 4.52 5.83
OPM % 9.48% 8.77% 8.99% 9.15% 5.74% 6.77%
0.10 0.01 0.01 0.01 0.03 0.00
Interest 1.68 1.71 1.87 2.03 1.71 1.63
Depreciation 1.76 1.63 1.56 1.43 1.37 1.35
Profit before tax 2.25 1.24 0.62 0.69 1.47 2.85
Tax % 28.89% 20.97% 25.81% 50.72% 28.57%
1.59 0.99 0.47 0.34 1.06 2.05
EPS in Rs 1.82 1.06 0.47 0.34 0.80 1.60
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 15%
TTM: 83%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 2%
TTM: 377%
Stock Price CAGR
10 Years: 3%
5 Years: 24%
3 Years: 32%
1 Year: 12%
Return on Equity
10 Years: %
5 Years: 3%
3 Years: 2%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8.74 9.32 10.00 10.00 13.18
Reserves 19.62 22.38 23.82 24.11 35.34
16.43 16.96 17.52 19.24 14.51
11.66 9.57 7.46 11.80 11.86
Total Liabilities 56.45 58.23 58.80 65.15 74.89
13.97 12.92 11.68 12.21 11.58
CWIP 0.55 0.92 1.63 2.00 2.43
Investments 0.00 0.89 0.84 0.80 0.78
41.93 43.50 44.65 50.14 60.10
Total Assets 56.45 58.23 58.80 65.15 74.89

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.77 1.66 0.79 3.72 -5.75
-2.44 -2.27 -1.01 -2.32 -1.13
1.68 0.62 0.28 -1.43 7.04
Net Cash Flow 0.01 0.02 0.07 -0.02 0.16
Free Cash Flow -1.69 0.80 -0.23 1.39 -6.92
CFO/OP 26% 45% 25% 95% -118%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 141.52 110.80 103.44 109.73 113.01
Inventory Days 151.64 178.58 251.53 261.81 137.69
Days Payable 62.25 46.92 34.02 78.95 38.15
Cash Conversion Cycle 230.90 242.47 320.95 292.59 212.56
Working Capital Days 112.48 152.43 132.77 124.01 145.97
ROCE % 6.31% 4.98% 5.20% 5.46%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Capital Expenditure on Fixed Assets
Rs. Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Purchases from Related Parties
Rs. Lakhs ・Standalone data
Sales to Related Parties
Rs. Lakhs ・Standalone data
Number of Employees
count ・Standalone data
Capital Work-in-Progress
Rs. Lakhs ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
52.13% 55.41% 55.41% 55.41% 54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 45.08%
47.87% 44.59% 44.60% 44.60% 45.61% 45.61% 45.61% 45.61% 45.61% 45.61% 45.61% 54.92%
No. of Shareholders 3,9574,0324,7344,7555,0735,0735,2525,1894,7184,5974,4644,435

Documents

Announcements

Annual reports

Credit ratings